BCM
SQZ

Bridgeway Capital Management’s SQZ Biotechnologies Company SQZ Stock Holding History

Bridgeway Capital Management’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-65,800
Closed -$17.8K – 1470
2023
Q2 		$17.8K Hold
65,800
– – ﹤0.01% 1365
2023
Q1 		$36.8K Hold
65,800
– – ﹤0.01% 1335
2022
Q4 		$48.7K Hold
65,800
– – ﹤0.01% 1300
2022
Q3 		$150K Buy
65,800
+25,000
+61% +$75K ﹤0.01% 1199
2022
Q2 		$130K Buy
40,800
+12,400
+44% +$44.6K ﹤0.01% 1177
2022
Q1 		$137K Buy
+28,400
New +$180K ﹤0.01% 1231

Other funds holding SQZ

AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bridgeway Capital Management's SQZ Position: Q3 2023 in Review

Bridgeway Capital Management sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 65,800 shares — an estimated $17.8K sold.

Bridgeway Capital Management first reported a position in SQZ in Q1 2022 and held it in 6 quarters. The position peaked at $150K in Q3 2022. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

  • Bridgeway Capital Management reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 65,800 SQZ Biotechnologies Company shares in Q3 2023, an estimated $17.8K.
  • Bridgeway Capital Management first reported a position in SQZ Biotechnologies Company in Q1 2022 and held it in 6 quarters.
  • Bridgeway Capital Management's SQZ Biotechnologies Company position peaked at $150K in Q3 2022.
  • 5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.